skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

The Impact of Delays in Chinese Approvals of Biotech Crops

Impact of chinese approvals on biotech crops

In recent years, China has taken considerably longer to approve new biotech crop “events” than have other countries. CropLife International (CLI) commissioned Informa’s Agribusiness Consulting Group (Informa) to conduct an analysis of the agricultural and broader economic impacts of these delays in Chinese approvals.


Informa’s analysis was conducted in two phases. The first phase focuses on biotech events approved by China over the last six years, while the second phase addresses conditions over the next 3-5 years.1 This report addresses each phase separately.

Click below to download the full 100-page summary.

What do you need to know? Speak to our team today.

For a personal discussion, contact us:

North America +1 (901) 766 4586
South America +55 (11) 4504-1447
EMEA +44 (20) 701 75956
APAC +852 2234 2919

consulting@agri.informa.com
Listen to Tom Scott, head of our global project consulting group, explain how consulting can help you and your business.
See how we help organizations around the world succeed through a blend of solid strategic vision and dependable execution.